We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals

21 hedge funds and large institutions have $3.37M invested in Armata Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

506% more capital invested

Capital invested by funds: $555K → $3.37M (+$2.81M)

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

17% more funds holding

Funds holding: 1821 (+3)

2.97% more ownership

Funds ownership: 1.64%4.6% (+3%)

Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

ARMP Hedge Fund Activity: Q2 2020 in Review

21 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q2 2020, worth a combined $3.37M — up 506% from $555K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ARMP positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Bank of America, adding an estimated $2.19M. The largest seller was Stifel Financial, cutting an estimated $9.95K.

  • 21 institutional investors held Armata Pharmaceuticals (ARMP) as of Q2 2020, up from 18 in Q1 2020.
  • Funds reported $3.37M of Armata Pharmaceuticals stock for Q2 2020, up 506% quarter-over-quarter.
  • 3 funds opened new Armata Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +3 holders.
  • The largest Armata Pharmaceuticals buyer in Q2 2020 was Bank of America, an estimated $2.19M added.
  • The largest Armata Pharmaceuticals seller in Q2 2020 was Stifel Financial, an estimated $9.95K sold.

Based on aggregated 13F filings for Q2 2020.